1. Home
  2. CING vs YMAT Comparison

CING vs YMAT Comparison

Compare CING & YMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • YMAT
  • Stock Information
  • Founded
  • CING 2012
  • YMAT 1970
  • Country
  • CING United States
  • YMAT Taiwan
  • Employees
  • CING N/A
  • YMAT N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • YMAT Recreational Games/Products/Toys
  • Sector
  • CING Health Care
  • YMAT Consumer Discretionary
  • Exchange
  • CING Nasdaq
  • YMAT Nasdaq
  • Market Cap
  • CING 21.6M
  • YMAT 17.4M
  • IPO Year
  • CING 2021
  • YMAT 2025
  • Fundamental
  • Price
  • CING $3.80
  • YMAT $1.05
  • Analyst Decision
  • CING Strong Buy
  • YMAT
  • Analyst Count
  • CING 4
  • YMAT 0
  • Target Price
  • CING $33.00
  • YMAT N/A
  • AVG Volume (30 Days)
  • CING 230.9K
  • YMAT 60.5K
  • Earning Date
  • CING 11-07-2025
  • YMAT 11-09-2025
  • Dividend Yield
  • CING N/A
  • YMAT N/A
  • EPS Growth
  • CING N/A
  • YMAT N/A
  • EPS
  • CING N/A
  • YMAT 0.07
  • Revenue
  • CING N/A
  • YMAT $17,563,985.00
  • Revenue This Year
  • CING N/A
  • YMAT N/A
  • Revenue Next Year
  • CING N/A
  • YMAT N/A
  • P/E Ratio
  • CING N/A
  • YMAT $12.25
  • Revenue Growth
  • CING N/A
  • YMAT N/A
  • 52 Week Low
  • CING $3.02
  • YMAT $0.80
  • 52 Week High
  • CING $6.01
  • YMAT $6.45
  • Technical
  • Relative Strength Index (RSI)
  • CING 47.04
  • YMAT N/A
  • Support Level
  • CING $3.55
  • YMAT N/A
  • Resistance Level
  • CING $4.04
  • YMAT N/A
  • Average True Range (ATR)
  • CING 0.28
  • YMAT 0.00
  • MACD
  • CING -0.02
  • YMAT 0.00
  • Stochastic Oscillator
  • CING 29.41
  • YMAT 0.00

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

About YMAT J-Star Holding Co. Ltd. Ordinary Shares

J Star Holding Co Ltd is engaged in the research, development and manufacturing of carbon fiber for a wide variety of products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products.

Share on Social Networks: